Krsnaa Diagnostics Limited (KRSNAA) Price & Analysis

Compare

1 Followers

KRSNAA Stock Chart & Stats

₹735.10

₹3.75(0.41%)

At close: Jan 08 4:00 PM EST

₹735.10

₹3.75(0.41%)

Day’s Range― - ―

52-Week Range₹581.00 - ₹891.80

Previous CloseN/A

Volume110.72K

Average Volume (3M)12.28K

Market Cap

₹19.60B

Enterprise Value₹22.38B

Total Cash (Recent Filing)₹1.60B

Total Debt (Recent Filing)₹2.86B

Price to Earnings (P/E)38.4

Beta0.97

Next Earnings

Jun 03, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.38%

Share Statistics

EPS (TTM)4.90

Shares Outstanding32,438,670

10 Day Avg. Volume19,408

30 Day Avg. Volume12,281

Financial Highlights & Ratios

PEG Ratio0.98

Price to Book (P/B)2.95

Price to Sales (P/S)3.63

P/FCF Ratio-66.26

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)37.05

Revenue Forecast (FY)₹8.35B

Bulls Say, Bears Say

Bulls Say

Strong Balance SheetA high equity ratio and low leverage provide durable financial resilience, lowering refinancing and solvency risk. This capital structure supports continued investment in labs and imaging, enabling contract bids and buffering operational shocks over the next several quarters.

Robust Revenue Growth And Gross MarginsSustained double-digit revenue growth and very high gross margins indicate efficient clinical operations and pricing power in testing services. Durable margin headroom supports reinvestment in capacity and technology, underpinning medium‑term profitability sustainability.

PPP / Institutional Revenue FranchiseA business model centered on PPPs and government contracts provides predictable baseline volumes and long contract tenors, anchoring utilization of assets and steady institutional revenues. This structural revenue base supports multi‑quarter planning and capacity utilization.

Bears Say

Negative Free Cash FlowPersistent negative free cash flow driven by capital spending reduces financial flexibility and may force higher external financing or slower expansion. Over several quarters this constrains the company’s ability to self‑fund new centers or absorb shocks without altering capex plans.

Moderate Operating ProfitabilityWhile profitable, mid‑teens EBIT and single‑digit to low double‑digit net margins leave limited buffer against tariff cuts or pricing pressure. Improving operating efficiency or scale is needed to materially enhance durable shareholder returns and resilience to cost inflation.

Revenue Tied To Contract Terms And RenewalsReliance on government and institutional contract tariffs and renewal cycles creates structural revenue and pricing risk. Long‑term growth depends on winning/renewing tenders and negotiated tariffs, which can constrain top‑line visibility and margin stability across quarters.

Krsnaa Diagnostics Limited News

Krsnaa Diagnostics Publishes Postal Ballot Notice for Shareholder E-Voting

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) just unveiled an announcement. Krsnaa Diagnostics Limited has notified stock exchanges that...

3d ago

Krsnaa Diagnostics Extends Tenure of Executive Chairman Rajendra Mutha

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has shared an update. Krsnaa Diagnostics Limited’s board has approved the re-appointment...

25d ago

Krsnaa Diagnostics Reappoints Executive Chairman Rajendra Mutha for Five-Year Term

An announcement from Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) is now available. Krsnaa Diagnostics Limited has approved the...

25d ago

Krsnaa Diagnostics Publishes Q3 FY26 Earnings Call Transcript

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has provided an update. Krsnaa Diagnostics Limited has released the transcript of...

1M ago

Krsnaa Diagnostics Plans Mumbai Investor Meeting Under SEBI Norms

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) just unveiled an announcement. Krsnaa Diagnostics has scheduled a one-on-one physical meeting...

1M ago

Krsnaa Diagnostics Publishes Unaudited Q3 and Nine-Month FY26 Results in Newspapers

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) just unveiled an announcement. Krsnaa Diagnostics Limited has published newspaper advertisements of...

1M ago

Krsnaa Diagnostics Schedules One-on-One Investor Meet in Mumbai

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) just unveiled an update. Krsnaa Diagnostics Limited has informed the stock exchanges...

2M ago

Krsnaa Diagnostics Schedules Investor Meeting for November 27

An update from Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) is now available. Krsnaa Diagnostics Limited has announced a...

4M ago

Krsnaa Diagnostics Releases Unaudited Financial Results for September 2025

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has issued an announcement. Krsnaa Diagnostics Limited announced the publication of its...

4M ago

Krsnaa Diagnostics Achieves Record Profit, Eyes Future Growth with Rajasthan Expansion

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has provided an update. Krsnaa Diagnostics Limited reported its highest-ever quarterly profit,...

4M ago

KRSNAA FAQ

What was Krsnaa Diagnostics Limited’s price range in the past 12 months?

Krsnaa Diagnostics Limited lowest stock price was ₹581.00 and its highest was ₹891.80 in the past 12 months.

What is Krsnaa Diagnostics Limited’s market cap?

Krsnaa Diagnostics Limited’s market cap is ₹19.60B.

When is Krsnaa Diagnostics Limited’s upcoming earnings report date?

Krsnaa Diagnostics Limited’s upcoming earnings report date is Jun 03, 2026 which is in 76 days.

How were Krsnaa Diagnostics Limited’s earnings last quarter?

Krsnaa Diagnostics Limited released its earnings results on Feb 05, 2026. The company reported ₹4.9 earnings per share for the quarter, missing the consensus estimate of ₹6.067 by -₹1.167.

Is Krsnaa Diagnostics Limited overvalued?

According to Wall Street analysts Krsnaa Diagnostics Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Krsnaa Diagnostics Limited pay dividends?

Krsnaa Diagnostics Limited pays a Annually dividend of ₹2.75 which represents an annual dividend yield of 0.38%. See more information on Krsnaa Diagnostics Limited dividends here

What is Krsnaa Diagnostics Limited’s EPS estimate?

Krsnaa Diagnostics Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Krsnaa Diagnostics Limited have?

Krsnaa Diagnostics Limited has 32,438,670 shares outstanding.

What happened to Krsnaa Diagnostics Limited’s price movement after its last earnings report?

Krsnaa Diagnostics Limited reported an EPS of ₹4.9 in its last earnings report, missing expectations of ₹6.067. Following the earnings report the stock price went down -0.776%.

Which hedge fund is a major shareholder of Krsnaa Diagnostics Limited?

Currently, no hedge funds are holding shares in IN:KRSNAA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited provides diagnostic services. The company offers a range of technology-enabled diagnostic services, such as radiology, pathology/clinical laboratory, and tele-radiology services to public and private hospitals, medical colleges, and community health centers. As of December 31, 2020, it operated 1,801 diagnostic centers in 13 states across India. The company was incorporated in 2010 and is based in Pune, India.